Found: 782
Select item for more details and to access through your institution.
Decoding the genetic influence of CT60 non-coding polymorphism in CTLA-4 gene and sCTLA-4 biomarker with rheumatoid arthritis in the Indian population.
- Published in:
- Molecular Biology Reports, 2024, v. 51, n. 1, p. 1, doi. 10.1007/s11033-024-09949-w
- By:
- Publication type:
- Article
Proteomic Investigation of Immune Checkpoints and Some of Their Inhibitors.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 17, p. 9276, doi. 10.3390/ijms25179276
- By:
- Publication type:
- Article
TRMT10C gene polymorphisms confer hepatoblastoma susceptibility: evidence from a seven-center case-control study.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 16, p. 5396, doi. 10.7150/jca.98555
- By:
- Publication type:
- Article
Advances in understanding the role of immune checkpoint LAG-3 in tumor immunity: a comprehensive review.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1402837
- By:
- Publication type:
- Article
Editorial: Crosstalk: skin cells and immune cells in inflammatory skin diseases.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1472313
- By:
- Publication type:
- Article
Targeting TNFR2 for cancer immunotherapy: recent advances and future directions.
- Published in:
- Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-024-05620-x
- By:
- Publication type:
- Article
Blockade of the Activation of T Cells Around β-Cell by the Targeted CTLA-4 Ig at the Surface of β-Cell.
- Published in:
- Cell Biochemistry & Biophysics, 2015, v. 71, n. 2, p. 913, doi. 10.1007/s12013-014-0282-0
- By:
- Publication type:
- Article
Evaluation of vitamin D receptor gene polymorphisms (ApaI and TaqI) as risk factors of vitiligo and predictors of response to narrowband UVB phototherapy.
- Published in:
- Archives of Dermatological Research, 2023, v. 315, n. 3, p. 379, doi. 10.1007/s00403-022-02348-w
- By:
- Publication type:
- Article
Cytotoxic T‑lymphocyte antigen‑4 Gene Polymorphism are Associated with High Immune Response to BNT62b2 Coronavirus Disease 2019 Vaccine and Low Level of Soluble Immune Check Point in Iraqi Subjects.
- Published in:
- Biomedical & Biotechnology Research Journal, 2023, v. 7, n. 3, p. 478, doi. 10.4103/bbrj.bbrj_175_23
- By:
- Publication type:
- Article
Immunogenetics: Human CTLA4 mutations described.
- Published in:
- Nature Reviews Immunology, 2014, v. 14, n. 10, p. 648, doi. 10.1038/nri3752
- By:
- Publication type:
- Article
山萘酚通过增强Treg细胞免疫抑制功能延长移植物生存时间.
- Published in:
- Progress in Modern Biomedicine, 2020, v. 20, n. 2, p. 220, doi. 10.13241/j.cnki.pmb.2020.02.004
- By:
- Publication type:
- Article
Elevated circulating cytotoxic T lymphocyte-associated antigen-4 levels are related to lung function and inflammation in chronic obstructive pulmonary disease.
- Published in:
- Respirology, 2013, v. 18, n. 5, p. 885, doi. 10.1111/resp.12113
- By:
- Publication type:
- Article
Memory of tolerance and induction of regulatory T cells by erythrocyte-targeted antigens.
- Published in:
- Scientific Reports, 2015, p. 15907, doi. 10.1038/srep15907
- By:
- Publication type:
- Article
Network analysis of immunotherapy-induced regressing tumours identifies novel synergistic drug combinations.
- Published in:
- Scientific Reports, 2015, p. 12298, doi. 10.1038/srep12298
- By:
- Publication type:
- Article
The Importance of HHLA2 in Solid Tumors—A Review of the Literature.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 10, p. 794, doi. 10.3390/cells13100794
- By:
- Publication type:
- Article
The Use of Immune Regulation in Treating Head and Neck Squamous Cell Carcinoma (HNSCC).
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 5, p. 413, doi. 10.3390/cells13050413
- By:
- Publication type:
- Article
Comprehensive Co-Inhibitory Receptor (Co-IR) Expression on T Cells and Soluble Proteins in Rheumatoid Arthritis.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 5, p. 403, doi. 10.3390/cells13050403
- By:
- Publication type:
- Article
Five Inhibitory Receptors Display Distinct Vesicular Distributions in Murine T Cells.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 21, p. 2558, doi. 10.3390/cells12212558
- By:
- Publication type:
- Article
A Mathematical Model for Predicting Patient Responses to Combined Radiotherapy with CTLA-4 Immune Checkpoint Inhibitors.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 9, p. 1305, doi. 10.3390/cells12091305
- By:
- Publication type:
- Article
Distinct Dynamics of Migratory Response to PD-1 and CTLA-4 Blockade Reveals New Mechanistic Insights for Potential T-Cell Reinvigoration following Immune Checkpoint Blockade.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 22, p. 3534, doi. 10.3390/cells11223534
- By:
- Publication type:
- Article
Metabolic Implications of Immune Checkpoint Proteins in Cancer.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 1, p. 179, doi. 10.3390/cells11010179
- By:
- Publication type:
- Article
Differential Response of MDA-MB-231 and MCF-7 Breast Cancer Cells to In Vitro Inhibition with CTLA-4 and PD-1 through Cancer-Immune Cells Modified Interactions.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 8, p. 2044, doi. 10.3390/cells10082044
- By:
- Publication type:
- Article
Identification of CTLA-4-Positive Cells in the Human Tonsil.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 5, p. 1027, doi. 10.3390/cells10051027
- By:
- Publication type:
- Article
CLTA-4 Expression Is Associated with the Maintenance of Chronic Inflammation in Endometriosis and Infertility.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 3, p. 487, doi. 10.3390/cells10030487
- By:
- Publication type:
- Article
Immune checkpoint blockade - a treatment for urological cancers?
- Published in:
- BJU International, 2016, v. 118, n. 4, p. 498, doi. 10.1111/bju.13571
- By:
- Publication type:
- Article
TNFSF13B rs9514828 gene polymorphism and soluble B cell activating factor levels: Association with apical periodontitis.
- Published in:
- International Endodontic Journal, 2023, v. 56, n. 4, p. 419, doi. 10.1111/iej.13879
- By:
- Publication type:
- Article
A meta-analysis of the efficacy of programmed cell death 1/its ligand inhibitors plus cytotoxic T-lymphocyte-associated antigen 4 inhibitors in non-small cell lung cancer.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1267763
- By:
- Publication type:
- Article
PD-1 and CTLA-4 exert additive control of effector regulatory T cells at homeostasis.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 01, doi. 10.3389/fimmu.2023.997376
- By:
- Publication type:
- Article
Quantitative and causal analysis for inflammatory genes and the risk of Parkinson’s disease.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1119315
- By:
- Publication type:
- Article
Epstein-Barr virus DNA seropositivity links distinct tumoral heterogeneity and immune landscape in nasopharyngeal carcinoma.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 01, doi. 10.3389/fimmu.2023.1124066
- By:
- Publication type:
- Article
Case report: Challenges in immune reconstitution following hematopoietic stem cell transplantation for CTLA-4 insufficiency-like primary immune regulatory disorders.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.1070068
- By:
- Publication type:
- Article
Tissue-resident memory T cells in the era of (Neo) adjuvant melanoma management.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.1048758
- By:
- Publication type:
- Article
Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency?
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1011646
- By:
- Publication type:
- Article
Pattern recognition receptor CD14 gene polymorphisms in alcohol use disorder patients and its Influence on liver disease susceptibility.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.975027
- By:
- Publication type:
- Article
Cardiotoxicity of immune checkpoint inhibitors: A frequency network meta-analysis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1006860
- By:
- Publication type:
- Article
Adenosinergic axis and immune checkpoint combination therapy in tumor: A new perspective for immunotherapy strategy.
- Published in:
- Frontiers in Immunology, 2022, v. 12, p. 1, doi. 10.3389/fimmu.2022.978377
- By:
- Publication type:
- Article
Impact of CTLA-4 checkpoint antibodies on ligand binding and Transendocytosis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.871802
- By:
- Publication type:
- Article
Anti-CD40 predominates over anti-CTLA-4 to provide enhanced antitumor response of DC-CIK cells in renal cell carcinoma.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.925633
- By:
- Publication type:
- Article
CTLA-4 silencing in dendritic cells loaded with colorectal cancer cell lysate improves autologous T cell responses in vitro.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.931316
- By:
- Publication type:
- Article
Molecular and Functional Analyses of the Primordial Costimulatory Molecule CD80/86 and Its Receptors CD28 and CD152 (CTLA-4) in a Teleost Fish.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.885005
- By:
- Publication type:
- Article
Co-Inhibitory Molecules – Their Role in Health and Autoimmunity; Highlighted by Immune Related Adverse Events.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.883733
- By:
- Publication type:
- Article
Holistic Approach to Immune Checkpoint Inhibitor-Related Adverse Events.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.804597
- By:
- Publication type:
- Article
Functional Diversities of Regulatory T Cells in the Context of Cancer Immunotherapy.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.833667
- By:
- Publication type:
- Article
Letter: anti- CTLA-4-associated colitis and inflammatory bowel disease pathogenesis - authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2015, v. 42, n. 8, p. 1032, doi. 10.1111/apt.13373
- By:
- Publication type:
- Article
Letter: anti- CTLA-4-associated colitis and inflammatory bowel disease pathogenesis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2015, v. 42, n. 8, p. 1031, doi. 10.1111/apt.13369
- By:
- Publication type:
- Article
First-line treatment of metastatic melanoma: role of nivolumab.
- Published in:
- ImmunoTargets & Therapy, 2017, v. 6, p. 1, doi. 10.2147/ITT.S110479
- By:
- Publication type:
- Article
Prolonged Disease Course of COVID-19 in a Patient with CTLA-4 Haploinsufficiency.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
The Role of Immune Checkpoint Inhibitors in Cancer Therapy.
- Published in:
- Clinics & Practice, 2023, v. 13, n. 1, p. 22, doi. 10.3390/clinpract13010003
- By:
- Publication type:
- Article
CNS demyelination associated with immune dysregulation and a novel CTLA-4 variant.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 9, p. 1464, doi. 10.1177/1352458520963896
- By:
- Publication type:
- Article
Expression of immune checkpoints in active nonsegmental vitiligo: a pilot study.
- Published in:
- International Journal of Dermatology, 2020, v. 59, n. 8, p. 982, doi. 10.1111/ijd.14983
- By:
- Publication type:
- Article